In tumor progression definite alterations in nuclear matrix (NM) protein composition as well as in chromatin structure occur. The NM interacts with chromatin via specialized DNA sequences called matrix attachment regions (MARs). In the present study, using a proteomic approach along with a two-dimensional Southwestern assay and confocal laser microscopy, we show that the differentiation of stabilized human prostate carcinoma cells is marked out by modifications both NM protein composition and bond between NM proteins and MARs. Well-differentiated androgen-responsive and slowly growing LNCaP cells are characterized by a less complex pattern and by a major number of proteins binding MAR sequences in comparison to 22Rv1 cells expressing androgen receptor but androgen-independent. Finally, in the poorly differentiated and strongly aggressive androgen-independent PC3 cells the complexity of NM pattern further increases and a minor number of proteins bind the MARs. Furthermore, in this cell line with respect to LNCaP cells, these changes are synchronous with modifications in both the nuclear distribution of the MAR sequences and in the average loop dimensions that significantly increase. Although the expression of many NM proteins changes during dedifferentiation, only a very limited group of MAR-binding proteins seem to play a key role in this process. Variations in the expression of poly (ADP-ribose) polymerase (PARP) and special AT-rich sequence-binding protein-1 (SATB1) along with an increase in the phosphorylation of lamin B represent changes that might trigger passage towards a more aggressive phenotype. These results suggest that elucidating the MAR-binding proteins that are involved in the differentiation of prostate cancer cells could be an important tool to improve our understanding of this carcinogenesis process, and they could also be novel targets for prostate cancer therapy.
References
[1]
Lever E, Sheer D (2010) The role of nuclear organization in cancer. J Pathol 220: 114–125.
[2]
Gluch A, Vidakovic M, Bode J (2008) Scaffold/matrix attachment regions (S/MARs): relevance for disease and therapy. Handb Exp Pharmacol 186: 67–103.
[3]
Razin SV (2001) The nuclear matrix and chromosomal DNA loops: is their any correlation between partitioning of the genome into loops and functional domains? Cell Mol Biol Lett 6: 59–69.
[4]
Barboro P, D’Arrigo C, Repaci E, Bagnasco L, Orecchia P, et al. (2009) Proteomic analysis of the nuclear matrix in the early stages of rat liver carcinogenesis: identification of differentially expressed and MAR-binding proteins. Exp Cell Res 315: 226–239.
[5]
Barboro P, D’Arrigo C, Repaci E, Patrone E, Balbi C (2010) Organization of the lamin scaffold in the internal nuclear matrix of normal and transformed hepatocytes. Exp Cell Res 316: 992–1001.
[6]
Pienta KJ, Bradley D (2006) Mechanisms underlying the development of androgen-independent prostate cancer. Clin Cancer Res 12: 1665–1671.
[7]
Leman ES, Getzenberg RH (2002) Nuclear matrix proteins as biomarkers in prostate cancer. J Cell Biochem 86: 213–223.
[8]
Barboro P, Rubagotti A, Boccardo F, Carnemolla B, D’Arrigo C, et al. (2005) Nuclear matrix protein expression in prostate cancer: possible prognostic and diagnostic applications. Anticancer Res 25: 3999–4004.
[9]
Barboro P, Repaci E, Rubagotti A, Salvi S, Boccardo S, et al. (2009) Heterogeneous nuclear ribonucleoprotein K: altered pattern of expression associated with diagnosis and prognosis of prostate cancer. Br J Cancer 100: 1608–1616.
[10]
Barboro P, D’Arrigo C, Diaspro A, Mormino M, Alberti I, et al. (2002) Unraveling the organization of the internal nuclear matrix: RNA-dependent anchoring of NuMA to a lamin scaffold. Exp Cell Res 279: 202–218.
[11]
Zeng C, McNeil S, Pockwinse S, Nickerson J, Shopland L, et al. (1998) Intranuclear targeting of AML/CBFalpha regulatory factors to nuclear matrix-associated transcriptional domains. Proc Natl Acad Sci USA 95: 1585–1589.
[12]
de Belle I, Cai S, Kohwi-Shigematsu T (1998) The genomic sequences bound to special AT-rich sequence-binding protein 1 (SATB1) in vivo in Jurkat T cells are tightly associated with the nuclear matrix at the bases of the chromatin loops. J Cell Biol 141: 335–348.
[13]
Guillou E, Ibarra A, Coulon V, Casado-Vela J, Rico D, et al. (2010) Cohesin organizes chromatin loops at DNA replication factories. Genes Dev 24: 2812–2822.
[14]
Barboro P, Rubagotti A, Orecchia P, Spina B, Truini M, et al. (2008) Differential proteomic analysis of nuclear matrix in muscle-invasive bladder cancer: potential to improve diagnosis and prognosis. Cell Oncol 30: 13–26.
[15]
Barboro P, Repaci E, Ferrari N, Rubagotti A, Boccardo F, et al. (2011) Androgen receptor and heterogeneous nuclear ribonucleoprotein K colocalize in the nucleoplasm and are modulated by bicalutamide and 4-hydroxy-tamoxifen in prostatic cancer cell lines. Prostate 71: 1466–1479.
[16]
Dworetzky SI, Fey EG, Penman S, Lian JB, Stein JL, et al. (1990) Progressive changes in the protein composition of the nuclear matrix during rat osteoblast differentiation. Proc Natl Acad Sc. USA 87: 4605–4609.
[17]
Coffey DS (2002) Nuclear matrix proteins as proteomic markers of preneoplastic and cancer lesions: commentary re: G. Brunagel, et al., Nuclear matrix protein alterations associated with colon cancer metastasis to the liver. Clin. Cancer Res., 8: 3039–3045, 2002. Clin Cancer Res 8: 3031–3033.
[18]
Virág L, Szabó C (2002) The therapeutic potential of poly(ADP-ribose) polymerase inhibitors. Pharmacol Rev 54: 375–429.
[19]
Gotzmann J, Meissner M, Gerner C (2000) The fate of the nuclear matrix-associated-region-binding protein SATB1 during apoptosis. Cell Death Differ 7: 425–438.
[20]
Notani D, Limaye AS, Kumar PP, Galande S (2010) Phosphorylation-dependent regulation of SATB1, the higher-order chromatin organizer and global gene regulator. Methods Mol Biol 647: 317–335.
[21]
Olson NE, Graves JD, Shu GL, Ryan EJ, Clark EA (2003) Caspase activity is required for stimulation B lymphocytes to enter the cell cycle. J Immunol 170: 6065–6072.
[22]
Seo J, Lozano MM, Dudley JP (2005) Nuclear matrix binding regulates SATB1-mediated transcriptional repression. J Biol Chem 280: 24600–24609.
[23]
Tan JA, Song J, Chen Y, Durrin LK (2010) Phosphorylation-dependent interaction of SATB1 and PIAS1 directs SUMO-regulated caspase cleavage of SATB1. Mol Cell Biol 30: 2823–2836.
[24]
Vidakovi？ M, Koester M, Goetze S, Winkelmann S, Klar M, et al. (2005) Co-localization of PARP-1 and lamin B in the nuclear architecture: a halo-fluorescence- and confocal-microscopy study. J Cell Biochem 96: 555–568.
[25]
Savarese F, Dávila A, Nechanitzky R, De La Rosa-Velazquez I, Pereira CF, et al. (2009) Satb1 and Satb2 regulate embryonic stem cell differentiation and Nanog expression. Genes Dev 23: 2625–2638.
[26]
Cai S, Han HJ, Kohwi-Shigematsu T (2003) Tissue-specific nuclear architecture and gene expression regulated by SATB1. Nat Genet 34: 42–51.
[27]
Ludérus ME, de Graaf A, Mattia E, den Blaauwen JL, Grande MA, et al. (1992) Binding of matrix attachment regions to lamin B1. Cell 70: 949–959.
[28]
Coradeghini R, Barboro P, Rubagotti A, Boccardo F, Parodi S, et al. (2006) Differential expression of nuclear lamins in normal and cancerous prostate tissues. Oncol Rep 15: 609–613.
[29]
Moir RD, Spann TP, Goldman RD (1995) The dynamic properties and possible functions of nuclear lamins. Int Rev Cyto 162B: 141–182.
[30]
Aranda-Anzaldo A (2009) A structural basis for cellular senescence. Aging (Albany NY) 1: 598–607.
[31]
Fraser P, Bickmore W (2007) Nuclear organization of the genome and the potential for gene regulation. Nature 447: 413–417.
[32]
Dundr M, Misteli T (2001) Functional architecture in the cell nucleus. Biochem J 356: 297–310.
[33]
Maya-Mendoza A, Hernández-Mu？oz R, Gariglio P, Aranda-Anzaldo A (2005) Natural ageing in the rat liver correlates with progressive stabilisation of DNA-nuclear matrix interactions and withdrawal of genes from the nuclear substructure. Mech Ageing Dev 126: 767–782.
[34]
Goes ACS, Cappellen D, Santos Jr GC, Pirozhkova I, Lipinski M, et al. (2011) Loop domain organization of the p53 locus in normal and breast cancer cells correlates with the transcriptional status of the TP53 and neighboring genes. J Cell Biochem 112: 2072–2081.
[35]
Vassetzky YS, Hair A, Razin SV (2000) Rearrangement of chromatin domains in cancer and development. J Cell Biochem S35: 54–60.
[36]
Misteli T (2010) Higher-order genome organization in human disease. Cold Spring Harb Perspect Biol 2: a000794.
[37]
Alva-Medina J, Maya-Mendoza A, Dent MAR, Aranda-Anzaldo A (2011) Continued stabilization of nuclear higher-order structure of post–mitotic neurons in vivo. PLoS One 6: e21360.
[38]
Galande S, Kohwi-Shigematsu T (2000) Linking chromatin architecture to cellular phenotype: BUR-binding proteins in cancer. J Cell Biochem S35: 36–45.
[39]
Shi L, Ko S, Kim S, Echchgadda I, Oh TS, et al. (2008) Loss of androgen receptor in aging and oxidative stress through Myb protooncoprotein-regulated reciprocal chromatin dynamics of p53 and poly(ADP-ribose) polymerase PARP-1. J Biol Chem 283: 36474–36485.
[40]
Galande S, Purbey PK, Notani D, Kumar PP (2007) The third dimension of gene regulation: organization of dynamic chromatin loopscape by SATB1. Curr Opin Genet Dev 17: 408–414.
[41]
Han HJ, Russo J, Kohwi Y, Kohwi-Shigematsu T (2008) SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis. Nature 452: 187–193.
[42]
Iorns E, Hnatyszyn HJ, Seo P, Clarke J, Ward T, et al. (2010) The role of SATB1 in breast cancer pathogenesis. J Natl Cancer Inst 102: 1284–1296.
[43]
Selinger CI, Cooper WA, Al-Sohaily S, Mladenova DN, Pangon L, et al. (2011) Loss of Special AT-Rich Binding Protein 1 Expression is a Marker of Poor Survival in Lung Cancer. J Thorac Oncol 6: 1179–1189.
[44]
Lin C, Yang L, Tanasa B, Hutt K, Ju BG, et al. (2009) Nuclear receptor-induced chromosomal proximity and DNA breaks underlie specific translocations in cancer. Cell 139: 1069–1083.
